XP Inc.
19.04USD
-0.9500 (-4.75%)
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $2.75▲ | $2.7 | 2 | 0 |
| Next quarter | $2.96▲ | $2.85 | 2 | 0 |
| Current year | $10.83▼ | $10.86 | 2 | 0 |
| Next year | $12.18▼ | $12.24 | 3 | 0 |
Beat in 3 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $2.62 | $2.67 | +0.05 (+2.0%) |
| 2026-03-31 | $2.53 | $2.49 | -0.04 (-1.7%) |
| 2025-12-31 | $2.5 | $2.56 | +0.06 (+2.4%) |
| 2025-09-30 | $2.42 | $2.47 | +0.05 (+2.2%) |
57 ratings from 11 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| Itau BBA | Upgraded from Market Perform | Outperform | $22 | Aug 31, 2026 |
| UBS | Maintained | Buy | $28 $25 | Jun 3, 2026 |
| UBS | Maintained | Buy | $25 $28 | Apr 2, 2026 |
| Jefferies | Initiated | Buy | $22 | Jan 20, 2026 |
| UBS | Maintained | Buy | $23 $25 | Dec 16, 2025 |
| UBS | Maintained | Buy | $24 $23 | Oct 16, 2025 |
| Citigroup | Maintained | Buy | $22 $23 | Sep 24, 2025 |
| UBS | Maintained | Buy | $17 $24 | Jun 10, 2025 |
| Goldman Sachs | Upgraded from Neutral | Buy | $17 $23 | Jun 4, 2025 |
| Goldman Sachs | Maintained | Neutral | $15 $17 | May 21, 2025 |
| B of A Securities | Maintained | Neutral | $16 $19 | May 21, 2025 |
| Morgan Stanley | Upgraded from Equal-Weight | Overweight | $18 $24 | May 13, 2025 |
| UBS | Changed from Neutral | Buy | $16 $17 | Apr 7, 2025 |
| Goldman Sachs | Maintained | Neutral | $19 $13 | Jan 27, 2025 |
| UBS | Upgraded from Neutral | Buy | $19 $16 | Jan 24, 2025 |
| B of A Securities | Downgraded from Buy | Neutral | $25 $16 | Dec 10, 2024 |
| Morgan Stanley | Maintained | Equal-Weight | $24 $21 | Nov 26, 2024 |
| JP Morgan | Maintained | Overweight | $28 $29 | Oct 16, 2024 |
| Goldman Sachs | Maintained | Neutral | $22 $19 | Jul 30, 2024 |
| UBS | Downgraded from Buy | Neutral | $30 $21 | Jul 11, 2024 |
| B of A Securities | Maintained | Buy | $31 $25 | Jun 17, 2024 |
| Citigroup | Maintained | Buy | $29 $27 | Jun 5, 2024 |
| Goldman Sachs | Downgraded from Buy | Neutral | $30 $23 | Apr 30, 2024 |
| Morgan Stanley | Downgraded from Overweight | Equal-Weight | $31 $24 | Apr 23, 2024 |
| Citigroup | Maintained | Buy | $28 $29 | Mar 22, 2024 |
No analyst notes on XP yet.
Analyst Ratings
11 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 2 | 3 | 1 | 0 | 0 | Buy1.83 |
| 1 mo ago | 2 | 3 | 1 | 0 | 0 | Buy1.83 |
| 2 mo ago | 3 | 6 | 2 | 0 | 0 | Buy1.91 |
| 3 mo ago | 3 | 7 | 3 | 0 | 0 | Buy2.00 |